Investec Bank plc has filed a Form 8.5 regulatory disclosure revealing significant trading activity in Advanced Medical Solutions Group plc (AMS.L) shares.
The disclosure was made under Rule 8.5 of the Takeover Code, which governs public dealing disclosures by exempt principal traders with recognised intermediary status.
Investec Bank plc acted in a client-serving capacity during the dealings, a standard arrangement for firms operating as exempt principal traders under the Code.
The bank serves as Advisor and Joint Broker to Advanced Medical Solutions Group plc, establishing its connection to the offer party named in the disclosure.
The dealings were undertaken on 23rd July 2026, with the formal disclosure document published on 24th July 2026.
Trading activity covered ordinary shares in Advanced Medical Solutions Group plc, with both purchase and sale transactions recorded during the dealing period.
Investec Bank plc purchased a total of 640,099 ordinary shares, with prices ranging from a low of 280 pence per unit to a high of 280.25 pence per unit.
On the sales side, Investec Bank executed transactions covering 650,000 ordinary shares, with all sales completed at a price of 280 pence per unit.
The disclosure confirmed that no cash-settled derivative transactions, stock-settled derivative transactions, or options activity formed part of the reported dealings.
Investec Bank also confirmed there are no indemnity arrangements, option agreements, or understandings that could constitute an inducement to deal or refrain from dealing in the relevant securities.
No agreements relating to voting rights or future acquisition and disposal of relevant securities through derivatives were reported by the exempt principal trader.
The contact named on the disclosure is Priyali Bhattacharjee, reachable by telephone for any queries relating to the filing and its contents.
Regulatory disclosures of this nature under Rule 8 of the Takeover Code are required to be submitted to a recognised Regulatory Information Service as a matter of compliance.
